FOSLEVODOPA WITH FOSCARBIDOPA

Brand name:

• Vyalev®

Pharmaceutical company:

ABBVIE PTY LTD

Condition/indication:
(therapeutic use)

• Advanced Parkinson Disease

PBAC Submission type:

New PBS listing (–)

Comment:

--

Public Summary Document:

Not yet available

Related medicines:

• FOSLEVODOPA WITH FOSCARBIDOPA

Submission received for:

May 2024 PBAC meeting

Opportunity for consumer comment:

Open 29/03/2023 and close 24/05/2023 (see PBS Website)

PBAC meeting:

Held on 10/05/2024

PBAC outcome published:

Not Recommended (see PBAC Outcomes)

5Lodgement of required documentation:

Has not yet commenced

6Agreement to listing arrangements:

Has not yet commenced

7Government processes:

Has not yet commenced

8Medicine listed on the PBS:

Has not yet occurred

---